Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.

NCT03863041 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT03863041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03863041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.
Lead sponsor
Poitiers University Hospital
Phase
Not applicable
Overall status
Completed
Start date
April 8, 2019
Completion date
June 15, 2023
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, magnetic resonance spectroscopy, memory complaint, phosphorylated metabolism profile